Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

Similar articles for PubMed (Select 24107731)

1.

Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.

Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.

J Hypertens. 2013 Oct;31(10):1998-2004. doi: 10.1097/HJH.0b013e3283630362. Erratum in: J Hypertens. 2014 Mar;32(3):702.

PMID:
24107731
2.
3.

Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.

Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.

Hum Reprod. 2014 Sep;29(9):2041-9. doi: 10.1093/humrep/deu180. Epub 2014 Jul 17.

PMID:
25035436
4.

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.

Meyer C, McGrath BP, Teede HJ.

J Clin Endocrinol Metab. 2005 Oct;90(10):5711-6. Epub 2005 Jul 26.

PMID:
16046590
5.

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.

Zueff LF, Martins WP, Vieira CS, Ferriani RA.

Ultrasound Obstet Gynecol. 2012 Mar;39(3):341-7. doi: 10.1002/uog.10084. Epub 2012 Feb 9.

6.

Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.

Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I.

Metabolism. 2012 Feb;61(2):193-201. doi: 10.1016/j.metabol.2011.06.005. Epub 2011 Aug 4.

PMID:
21820132
7.

[Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].

Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E.

Endocrinol Nutr. 2009 Feb;56(2):59-65. doi: 10.1016/S1575-0922(09)70553-4. Epub 2009 May 1. Spanish.

PMID:
19627713
8.

Vascular function in the diagnostic categories of polycystic ovary syndrome.

Moran LJ, Cameron JD, Strauss BJ, Teede HJ.

Hum Reprod. 2011 Aug;26(8):2192-9. doi: 10.1093/humrep/der159. Epub 2011 May 25.

9.

Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women.

Park JS, Nam JS, Cho MH, Yoo JS, Ahn CW, Jee SH, Lee HS, Cha BS, Kim KR, Lee HC.

Menopause. 2010 Jul;17(4):779-84. doi: 10.1097/gme.0b013e3181cd3d60.

PMID:
20215975
10.

Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.

Vryonidou A, Papatheodorou A, Tavridou A, Terzi T, Loi V, Vatalas IA, Batakis N, Phenekos C, Dionyssiou-Asteriou A.

J Clin Endocrinol Metab. 2005 May;90(5):2740-6. Epub 2005 Mar 1.

PMID:
15741256
11.

Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?

Soares GM, Vieira CS, Martins WP, Franceschini SA, dos Reis RM, Silva de Sá MF, Ferriani RA.

Clin Endocrinol (Oxf). 2009 Sep;71(3):406-11. doi: 10.1111/j.1365-2265.2008.03506.x. Epub 2008 Dec 15.

PMID:
19094071
12.

Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study.

Calderon-Margalit R, Siscovick D, Merkin SS, Wang E, Daviglus ML, Schreiner PJ, Sternfeld B, Williams OD, Lewis CE, Azziz R, Schwartz SM, Wellons MF.

Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2688-94. doi: 10.1161/ATVBAHA.114.304136. Epub 2014 Oct 30.

PMID:
25359859
13.

Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.

Lambrinoudaki I.

Maturitas. 2011 Jan;68(1):13-6. doi: 10.1016/j.maturitas.2010.09.005. Epub 2010 Oct 12. Review.

PMID:
20943333
14.

Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.

Bajuk Studen K, Jensterle Sever M, Pfeifer M.

Front Horm Res. 2013;40:64-82. doi: 10.1159/000341838. Epub 2012 Oct 18. Review.

PMID:
24002406
15.

Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.

Krentz AJ, von Mühlen D, Barrett-Connor E.

Metabolism. 2012 Sep;61(9):1238-41. doi: 10.1016/j.metabol.2012.02.001. Epub 2012 May 5.

PMID:
22560129
16.

Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.

Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P.

Metabolism. 2006 Apr;55(4):508-14.

PMID:
16546482
17.

Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).

Atiomo WU, Fox R, Condon JE, Shaw S, Friend J, Prentice AG, Wilkin TJ.

Clin Endocrinol (Oxf). 2000 Apr;52(4):487-92.

PMID:
10762292
18.

A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.

Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS.

J Clin Endocrinol Metab. 2008 Feb;93(2):470-6. Epub 2007 Dec 4.

PMID:
18056772
19.

Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.

Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F.

Hum Reprod. 2008 Jan;23(1):153-9. Epub 2007 Nov 16.

20.

Polycystic ovaries - beyond menopause.

Shah D, Bansal S.

Climacteric. 2014 Apr;17(2):109-15. doi: 10.3109/13697137.2013.828687. Epub 2013 Oct 28. Review.

PMID:
23895379
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk